Biogen Inc (0R1B.L) Stock Price

$139 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    7

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Biogen Inc, AI stock picks, stock alerts and much more.

Sign up

0R1B.L AI Stock Analysis

AI stock analysis for 0R1B.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Biogen Inc (0R1B.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Biogen Inc (0R1B.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Biogen Inc (0R1B.L), currently trading at $139, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0R1B.L

LSE

  • Biogen, Inc.

  • Symbol

    0R1B.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    20.4B

Similar Stocks

0QZU.L Vertex Pharmaceuticals Incorporated
0QZU.L		 $398.5
0.5%
7
0K6R.L Neurocrine Biosciences
0K6R.L		 $136.1
1.2%
7
0IGA.L Emergent BioSolutions Inc.
0IGA.L		 $9.46
2.9%
4
0H7R.L Abeona Therapeutics Inc.
0H7R.L		 $7.25
1.7%
5
0LSZ.L Walgreens Boots Alliance
0LSZ.L		 $12.17
0.5%
5

News

Wedbush Comments on Biogen’s Q2 Earnings (NASDAQ:BIIB)

Wedbush Comments on Biogen’s Q2 Earnings (NASDAQ:BIIB)
April 19, 2025. ETF Daily News
Leerink Partnrs Has Pessimistic View of Biogen Q1 Earnings

Leerink Partnrs Has Pessimistic View of Biogen Q1 Earnings
April 17, 2025. ETF Daily News
Research Analysts Set Expectations for Biogen Q1 Earnings

Research Analysts Set Expectations for Biogen Q1 Earnings
April 17, 2025. ETF Daily News
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion

Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
April 16, 2025. Biztoc.com

0R1B.L Alternative Data

Web Traffic

Biogen Inc receives an estimated 172646 monthly visitors to biogen.com.

  • Web Traffic

    172646

  • Change from Previous Month

    44%

  • 3 Month Change

    36.2%

  • YoY Change

    36.2%

Twitter Followers

Biogen Inc has 44,974 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    44974

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.1%

  • YoY Change

    0.1%

Facebook Engagement

Biogen Inc has engaged 2,598 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    2598

  • Daily Change

    12.9%

  • 1 Month Change

    1716.8%

  • 3 Month Change

    1523.8%

  • YoY Change

    1523.8%

Youtube Subscribers

Biogen Inc has 10,500 subscribers on its main Youtube channel.

  • Youtube Subscribers

    10500

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1.9%

Job Postings

Biogen Inc currenly has an estimated 200 open job postings, up by 2% over the last month.

  • Job Postings

    200

  • Daily Change

    1%

  • 1 Month Change

    2%

  • 3 Month Change

    96.1%

  • YoY Change

    96.1%

Reddit Mentions

Biogen Inc has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

1,143,041 are following Biogen Inc on LinkedIn, up by 1.4% over the last month.

  • LinkedIn Followers

    1143041

  • Daily Change

    1.4%

  • 1 Month Change

    1.4%

  • 3 Month Change

    2.8%

  • YoY Change

    2.8%

LinkedIn Employees

According to LinkedIn, Biogen Inc has 7,587 employees, down by -0.6% over the last month.

  • LinkedIn Employees

    7587

  • Daily Change

    0.6%

  • 1 Month Change

    0.6%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

Business Outlook

According to employee reviews, the business outlook among employees at Biogen Inc is 56 out of 100 (neutral).

  • Business Outlook

    56

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Biogen Inc was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0R1B.L Financials

0R1B.L Key Metrics

  • Total Revenue

    $2.4B

  • Net Income

    $240.5M

  • Earnings per Share

    $1.65

  • Free cash flow

    $296.4M

  • EBITDA

    $0

  • EBITDA Ratio

    0

  • Total Assets

    $28B

0R1B.L 2-year Revenue & Income
0R1B.L 2-year Free Cash Flow

0R1B.L Technicals

0R1B.L SMA
0R1B.L RSI

FAQ

What's the current price of Biogen Inc (0R1B.L) Stock?
The price of an Biogen Inc (0R1B.L) share is $139.

What's the market cap of Biogen Inc?
The current market cap of Biogen Inc is 20.4B.

Should I buy or sell 0R1B.L?
Biogen Inc shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Biogen Inc is better viewed as a hold or accumulate position while waiting for further developments.

Is Biogen Inc a good investment?
The current analysis of Biogen Inc's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Biogen Inc's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Biogen Inc (0R1B.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Biogen Inc stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Biogen Inc (0R1B.L) that investors often compare it to?
Biogen Inc (0R1B.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for Biogen Inc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Biogen Inc's stock price to be around $146.9 in 2026. Starting from the current price of $139, this represents a 5.7% change in price, indicating a bullish outlook for the stock.

How to buy Biogen Inc (0R1B.L) Stock?
Biogen Inc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Biogen Inc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.